Search research articles
Contact Us
Filters
Showing results (51-60 of 71) with videos related to
Page
of 8
Sort By:
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
June 22, 2019
No differential gene expression for CD4<sup>+</sup> T cells of MS patients and healthy controls
Ina S Brorson, Anna Eriksson, Ingvild S Leikfoss, et al.
Biochemical Pharmacology
|
August 14, 2010
Identification of AKN-032, a novel 2-aminopyrazine tyrosine kinase inhibitor, with significant preclinical activity in acute myeloid leukemia
Anna Eriksson, Martin Höglund, Elin Lindhagen, et al.
European Journal of Nutrition
|
June 25, 2011
Differential effects of 1α,25-dihydroxycholecalciferol on MCP-1 and adiponectin production in human white adipocytes
Silvia Lorente-Cebrián, Anna Eriksson, Thomas Dunlop, et al.
New Biotechnology
|
July 2, 2022
Plasma protein biomarker profiling reveals major differences between acute leukaemia, lymphoma patients and controls
Amal Abu Sabaa, Qiujin Shen, Emma Bergfelt Lennmyr, et al.
Biochemical Pharmacology
|
November 9, 2013
AKN-028 induces cell cycle arrest, downregulation of Myc associated genes and dose dependent reduction of tyrosine kinase activity in acute myeloid leukemia
Anna Eriksson, Antonia Kalushkova, Malin Jarvius, et al.
Clinical Proteomics
|
July 5, 2022
Quantitative proteomics reveals protein dysregulation during T cell activation in multiple sclerosis patients compared to healthy controls
Chiara Cappelletti, Anna Eriksson, Ina Skaara Brorson, et al.
British Journal of Haematology
|
February 28, 2020
Real-world data on treatment patterns and outcomes of hypomethylating therapy in patients with newly diagnosed acute myeloid leukaemia aged ≥ 60 years
Albin Österroos, Anna Eriksson, Petar Antunovic, et al.
Plos One
|
April 24, 2014
Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability
Erika Assarsson, Martin Lundberg, Göran Holmquist, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 17, 2021
THCz: Small molecules with antimicrobial activity that block cell wall lipid intermediates
Elisabeth Reithuber, Torbjörn Wixe, Kevin C Ludwig, et al.
Journal of Thrombosis and Haemostasis : JTH
|
April 28, 2021
An observational study to identify the prevalence of thrombocytopenia and anti-PF4/polyanion antibodies in Norwegian health care workers after COVID-19 vaccination
Ingvild Hausberg Sørvoll, Kjersti Daae Horvei, Siw Leiknes Ernstsen, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 71) with videos related to
Sort By:
Page
of 8
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
June 22, 2019
No differential gene expression for CD4<sup>+</sup> T cells of MS patients and healthy controls
Ina S Brorson, Anna Eriksson, Ingvild S Leikfoss, et al.
Biochemical Pharmacology
|
August 14, 2010
Identification of AKN-032, a novel 2-aminopyrazine tyrosine kinase inhibitor, with significant preclinical activity in acute myeloid leukemia
Anna Eriksson, Martin Höglund, Elin Lindhagen, et al.
European Journal of Nutrition
|
June 25, 2011
Differential effects of 1α,25-dihydroxycholecalciferol on MCP-1 and adiponectin production in human white adipocytes
Silvia Lorente-Cebrián, Anna Eriksson, Thomas Dunlop, et al.
New Biotechnology
|
July 2, 2022
Plasma protein biomarker profiling reveals major differences between acute leukaemia, lymphoma patients and controls
Amal Abu Sabaa, Qiujin Shen, Emma Bergfelt Lennmyr, et al.
Biochemical Pharmacology
|
November 9, 2013
AKN-028 induces cell cycle arrest, downregulation of Myc associated genes and dose dependent reduction of tyrosine kinase activity in acute myeloid leukemia
Anna Eriksson, Antonia Kalushkova, Malin Jarvius, et al.
Clinical Proteomics
|
July 5, 2022
Quantitative proteomics reveals protein dysregulation during T cell activation in multiple sclerosis patients compared to healthy controls
Chiara Cappelletti, Anna Eriksson, Ina Skaara Brorson, et al.
British Journal of Haematology
|
February 28, 2020
Real-world data on treatment patterns and outcomes of hypomethylating therapy in patients with newly diagnosed acute myeloid leukaemia aged ≥ 60 years
Albin Österroos, Anna Eriksson, Petar Antunovic, et al.
Plos One
|
April 24, 2014
Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability
Erika Assarsson, Martin Lundberg, Göran Holmquist, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 17, 2021
THCz: Small molecules with antimicrobial activity that block cell wall lipid intermediates
Elisabeth Reithuber, Torbjörn Wixe, Kevin C Ludwig, et al.
Journal of Thrombosis and Haemostasis : JTH
|
April 28, 2021
An observational study to identify the prevalence of thrombocytopenia and anti-PF4/polyanion antibodies in Norwegian health care workers after COVID-19 vaccination
Ingvild Hausberg Sørvoll, Kjersti Daae Horvei, Siw Leiknes Ernstsen, et al.
Page
of 8